MCA
IBB icon

Martin Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Martin Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Hold
13,419
– – 1.34% 17
2026
Q1 		$2.27M Sell
13,419
-600
-4% -$103K 1.43% 18
2025
Q4 		$2.37M Sell
14,019
-45
-0.3% -$7.31K 1.39% 18
2025
Q3 		$2.03M Sell
14,064
-75
-0.5% -$10.2K 1.23% 23
2025
Q2 		$1.79M Hold
14,139
– – 1.16% 25
2025
Q1 		$1.81M Sell
14,139
-300
-2% -$40.7K 1.29% 22
2024
Q4 		$1.91M Buy
14,439
+1,270
+10% +$179K 1.23% 23
2024
Q3 		$1.92M Buy
13,169
+133
+1% +$19.2K 1.37% 21
2024
Q2 		$1.79M Sell
13,036
-158
-1% -$21.1K 1.34% 24
2024
Q1 		$1.81M Sell
13,194
-180
-1% -$24.6K 1.42% 23
2023
Q4 		$1.82M Sell
13,374
-96
-0.7% -$11.7K 1.53% 21
2023
Q3 		$1.65M Buy
13,470
+249
+2% +$31.7K 1.6% 19
2023
Q2 		$1.68M Buy
13,221
+230
+2% +$29.9K 1.54% 20
2023
Q1 		$1.68M Sell
12,991
-995
-7% -$130K 1.73% 15
2022
Q4 		$1.84M Buy
13,986
+2,513
+22% +$325K 2.05% 14
2022
Q3 		$1.34M Sell
11,473
-7,424
-39% -$922K 1.97% 15
2022
Q2 		$2.22M Buy
18,897
+105
+0.6% +$12.5K 1.96% 15
2022
Q1 		$2.45M Buy
18,792
+340
+2% +$44.3K 1.68% 17
2021
Q4 		$2.82M Buy
+18,452
New +$2.86M 1.74% 16

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

Martin Capital Advisors's IBB Position: Q2 2026 in Review

Martin Capital Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 13,419 shares worth $2.55M. The position accounts for 1.34% of the portfolio, ranked #17.

Martin Capital Advisors first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.82M in Q4 2021. 410 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Martin Capital Advisors held 13,419 shares of iShares Biotechnology ETF worth $2.55M as of Q2 2026.
  • Martin Capital Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 1.34% of Martin Capital Advisors's portfolio in Q2 2026, its #17 holding.
  • Martin Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • Martin Capital Advisors's iShares Biotechnology ETF position peaked at $2.82M in Q4 2021.
  • 410 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Martin Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.